The Roadside Testing Assessment Rosita-2 project was carried out in 2003-2005 in order to evaluate the usability and analytical reliability of the onsite oral fluid (saliva) drug testing devices. 2046 subjects were included in the study and 2605 device evaluations were performed. Nine devices were evaluated: American Biomedica OralStat, Branan Medical Oratect, Cozart Bioscience RapiScan (only in the USA), Drager/Orasure DrugTest/Uplink, Lifepoint Impact, Securetec Drugwipe, Sun Biomedical OraLine, Ultimed SalivaScreen and Varian OraLab. The devices had tests for the following drugs: amphetamines, methamphetamine, cannabis, cocaine and opiates.Three devices also had a test for benzodiazepines. The Rosita-2 project was coordinated by Ghent University, Ghent, Belgium. (Author/publisher) For more information see http://www.rosita.org/ Please note that the results of most or all Rosita-2 evaluations are now obsolete. The results of a more recent (2010) evaluation can be found on the DRUID website (http://www.druid-project.eu).
Samenvatting